Patrick G. Holder

Patrick G. Holder

Auto-generated profile, based on publicly available information

Patrick G. Holder

Genentech Inc., South San Francisco, California. 1

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2007 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
EKErnest W. Kovacs
Ernest W. Kovacs
JHJacob Hooker
Jacob Hooker
DRDante W. Romanini
Dante W. Romanini
PHPatrick G. Holder
Patrick G. Holder
KBKatherine E. Berry
Katherine E. Berry
MFMatthew B. Francis
Matthew B. Francis

24 January 2022 in Advanced Drug Delivery Reviews
Verified
Journal Article
Open access
PHPatrick G. Holder
Patrick G. Holder
SLShion A. Lim
Shion A. Lim
CHChristine S. Huang
Christine S. Huang
PSPreeti Sharma
Preeti Sharma
YDYavuz S. Dagdas
Yavuz S. Dagdas
JSJonathan T. Sockolosky
Jonathan T. Sockolosky
Cytokines are a class of potent immunoregulatory proteins that are secreted in response to various stimuli and act locally to regulate many aspects of human physiology and disease. Cytokines play important roles in cancer initiation, progression, and elimination, and thus, there is a long clinical history associated with the use of recombinant cytokines to treat cancer. However, the use of cytokines as therapeutics has been limited by cytokine pleiotropy, complex biology, poor drug-like properties, and severe dose-limiting toxicities. Nevertheless, cytokines are crucial mediators of innate and adaptive antitumor immunity and have the potential to enhance immunotherapeutic approaches to treat cancer. Development of immune checkpoint inhibitors and combination immunotherapies has reinvigorated interest in cytokines as therapeutics, and a variety of engineering approaches are emerging to improve the safety and effectiveness of cytokine immunotherapy. In this review we highlight recent advances in cytokine biology and engineering for cancer immunotherapy.

24 May 2007 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
PHPatrick G. Holder
Patrick G. Holder
MFMatthew B. Francis
Matthew B. Francis

14 December 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
APArturo A. Pizano
Arturo A. Pizano
DLDaniel A. Lutterman
Daniel A. Lutterman
PHPatrick G. Holder
Patrick G. Holder
TTThomas S. Teets
Thomas S. Teets
JSJoAnne Stubbe
JoAnne Stubbe
DNDaniel G. Nocera
Daniel G. Nocera
Photochemical radical initiation is a powerful tool for studying radical initiation and transport in biology. Ribonucleotide reductases (RNRs), which catalyze the conversion of nucleotides to deoxynucleotides in all organisms, are an exemplar of radical mediated transformations in biology. Class Ia RNRs are composed of two subunits: α2 and β2. As a method to initiate radical formation photochemically within β2, a single surface-exposed cysteine of the β2 subunit of Escherichia coli Class Ia RNR has been labeled (98%) with a photooxidant ([Re ] = tricarbonyl(1,10-phenanthroline)(methylpyridyl)rhenium(I)). The labeling was achieved by incubation of S355C-β2 with the 4-(bromomethyl)pyridyl derivative of [Re] to yield the labeled species, [Re]-S355C-β2. Steady-state and time-resolved emission experiments reveal that the metal-to-ligand charge transfer (MLCT) excited-state 3 [Re ] ∗ is not significantly perturbed after bioconjugation and is available as a phototrigger of tyrosine radical at position 356 in the β2 subunit; transient absorption spectroscopy reveals that the radical lives for microseconds. The work described herein provides a platform for photochemical radical initiation and study of proton-coupled electron transfer (PCET) in the β2 subunit of RNR, from which radical initiation and transport for this enzyme originates.

28 November 2011 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
PHPatrick G. Holder
Patrick G. Holder
APArturo A. Pizano
Arturo A. Pizano
BABryce L. Anderson
Bryce L. Anderson
JSJoAnne Stubbe
JoAnne Stubbe
DNDaniel G. Nocera
Daniel G. Nocera

21 October 2010 in Langmuir
Verified
Journal Article
Closed access
PHPatrick G. Holder
Patrick G. Holder
DFDaniel T. Finley
Daniel T. Finley
NSNicholas Stephanopoulos
Nicholas Stephanopoulos
RWRoss Walton
Ross Walton
DCDouglas S. Clark
Douglas S. Clark
MFMatthew B. Francis
Matthew B. Francis